Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-07-116561
Filing Date
2007-05-16
Accepted
2007-05-16 11:49:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D dsc13da.htm SC 13D/A 46272
  Complete submission text file 0001193125-07-116561.txt   48232
Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Filed by) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 17841 FITCH IRVINE CA 92614
Business Address 5525 SOUTH 900 E SUITE 110 SALT LAKE CITY UT 84117 949 250 8686
eGENE, INC. (Subject) CIK: 0001105409 (see all company filings)

EIN.: 870645507
Type: SC 13D/A | Act: 34 | File No.: 005-80028 | Film No.: 07856628
SIC: 2834 Pharmaceutical Preparations